Long-Term Benefit from Adjuvant Tamoxifen in Luminal A and Luminal B Breast Cancer Patients

被引：0
|
作者：
Dar, Huma
Johansson, Annelie
Nordenskjold, Anna
Perez-Tenorio, Gizeh
Yau, Christina
Benz, Christopher C.
Esserman, Laura J.
Nordenskjold, Bo
Stal, Olle
Fornander, Tommy
Lindstrom, Linda S.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P2-03-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-03-04
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Long-term benefit from tamoxifen therapy for patients with Luminal A and Luminal B breast cancer: Retrospective analysis of the STO-3 trial.
    Lindstrom, Linda
    Yu, Nancy
    Iftimi, Adina
    Yau, Christina
    van 't Veer, Laura
    Nordenskjold, Bo
    Benz, Christopher
    Fornander, Tommy
    Stal, Olle
    Czene, Kamila
    Esserman, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Long-term tamoxifen benefit in pre- and postmenopausal patients of high and low risk with luminal A and B breast cancer
    Danielsson, O.
    Dar, H. A.
    Nordenskjold, A.
    Tenorio, G. Perez
    Yau, C.
    Benz, C.
    Van't Veer, L. J.
    Esserman, L.
    Nordenskjold, B. A.
    Fornander, T.
    Stal, O.
    Tobin, N. P.
    Johansson, A.
    Lindstrom, L. S.
    ANNALS OF ONCOLOGY, 2024, 35 : S346 - S346
  • [3] Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer
    Yu, Nancy Y.
    Iftimi, Adina
    Yau, Christina
    Tobin, Nicholas P.
    van 't Veer, Laura
    Hoadley, Katherine A.
    Benz, Christopher C.
    Nordenskjold, Bo
    Fornander, Tommy
    Stal, Olle
    Czene, Kamila
    Esserman, Laura J.
    Lindstrom, Linda S.
    JAMA ONCOLOGY, 2019, 5 (09) : 1304 - 1309
  • [4] Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancer
    Urso, Luca
    Quartuccio, Natale
    Caracciolo, Matteo
    Evangelista, Laura
    Schirone, Alessio
    Frassoldati, Antonio
    Arnone, Gaspare
    Panareo, Stefano
    Bartolomei, Mirco
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (02) : 212 - 219
  • [5] Adjuvant chemotherapy might show benefit in luminal B breast cancer patients with isolated locoregional recurrence
    Altundag, Kadri
    JOURNAL OF BUON, 2019, 24 (01): : 405 - 406
  • [6] Benefit of Adjuvant Chemotherapy in Luminal A Breast Cancers
    Heneghan, H. M.
    McDermott, A.
    Malone, C.
    McLaughlin, R.
    Sweeney, K. J.
    Kerin, M. J.
    CANCER RESEARCH, 2010, 70
  • [7] BENEFIT OF ADJUVANT CHEMOTHERAPY IN LUMINAL A BREAST CANCERS
    McDermott, A.
    Heneghan, H. M.
    Malone, C.
    McLaughlin, R.
    Sweeney, K. J.
    Kerin, M. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : 14 - 15
  • [8] TAMOXIFEN METABOLITES IN PATIENTS ON LONG-TERM ADJUVANT THERAPY FOR BREAST-CANCER
    LANGANFAHEY, SM
    TORMEY, DC
    JORDAN, VC
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (08) : 883 - 888
  • [9] Serum levels of the active tamoxifen metabolite Z-4OHtam is predictive of long-term survival in luminal B subtype of breast cancer patients
    Helland, Thomas
    Soiland, Havard
    Hustad, Steinar
    Lash, Timothy L.
    Kvaloy, Jan T.
    Renolen, Anne
    Borgen, Elin
    Bifulco, Ersilia
    Henne, Nina
    Lien, Ernst A.
    Mellgren, Gunnar
    Naume, Bjorn
    Janssen, Emiel A.
    CANCER RESEARCH, 2018, 78 (04)
  • [10] LONG-TERM ADJUVANT TAMOXIFEN THERAPY FOR BREAST-CANCER
    JORDAN, VC
    BREAST CANCER RESEARCH AND TREATMENT, 1990, 15 (03) : 125 - 136
12345